Delcasertib

DB05560InvestigationalProtein Based Therapies

Investigated for use/treatment in myocardial infarction.

Mechanism: Pharmacologically active on Protein kinase C delta type
Curator reviewed
Primary indication: Investigated for use/treatment in myocardial infarction.Curator reviewed
Code names: BMS-875944 · KAI-9803

Resolves to

Compound

Targets

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Delcasertib, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.